Insights On CONTRACT PHARMA MANUFACTURING

  1. Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables 10/20/2025

    Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

  2. Building Bioanalysis Infrastructure For Modern Drug Development 10/20/2025

    Drug development accelerates with AI, decentralized trials, and adaptive protocols, but legacy CRO infrastructure lags. Platform-based systems enable speed, quality, automation, and continuous improvement.

  3. 5 Outdated Practices Holding Back Modern Bioanalysis 10/20/2025

    Bioanalysis must replace outdated paper, manual processes, and disjointed systems with integrated, automated platforms for continuous validation, efficiency, compliance, and to support complex modern therapies.

  4. Built Like A Tech Company: Why CROs Need A New Operating System 10/20/2025

    See why building digital, automated infrastructure is essential, and better aligns CROs with today's speed, compliance, and innovation needs.

  5. medac CDMO Capacity Update October 2025: Fill/Finish 10/20/2025

    Find more than just reliable, flexible support along the entire value chain of injectables. Learn how dual-site EU-based operations provide scalable capacity and seamless global supply for your molecules.

  6. Regulatory Confidence, Manufacturing Excellence 10/20/2025

    With decades of experience, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.

  7. The Future Of Lentiviral Vector Innovation And Access 10/17/2025

    Founded on lentiviral vector design and manufacturing excellence, VBM and the LENTIVERSE™ technology platform provide a full suite of tools to quickly deliver state-of-the-art therapies and develop next-generation products.

  8. Small Molecule Oral Delivery For Rare Diseases: Complexities As A CDMO 10/16/2025

    Developing therapies for rare diseases faces hurdles like high costs, small patient populations, and complex small-batch manufacturing. CDMOs offer crucial support, expertise, and flexibility.

  9. How To Evaluate CDMO Communication: A Framework For Biotechs 10/16/2025

    Evaluate a CDMO's communication by assessing access, transparency, responsiveness, and scalability. Use a framework to ensure your partner builds a strong relationship that endures through any challenge.

  10. From Molecule To Market: Understanding The Roles Of CROs, CMOs, CDMOs 10/16/2025

    Understand the distinct roles of CROs, CMOs, and CDMOs in the journey from molecule to market. Choosing the right partner for your drug development stage is critical for success.